Skip to content

Homoeopathy in the treatment of Psoriasis

AN OPEN LABEL NON-RANDOMIZED CLINICAL TRIAL TO EVALUATE THE ROLE OF INDIVIDUALIZED HOMOEOPATHIC MEDICINE IN MANAGEMENT OF PATIENTS OF PSORIASIS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041787
Enrollment
45
Registered
2022-04-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

Intervention1: Individualized homeopathic medicine: Selection of individualized homeopathic medicine after thorough case taking, repertorial analysis and finally after consultation with Homeopathic Ma

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient suffering from psoriasis since at least 3 months. 2. Both male and female patients. 3. Age- 18-60 years. 4. Patients willing to participate in the study and giving written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patient who are unwilling to give consent. 2. Psoriasis with complications like erythroderma and pustules. 3. Diagnosed cases of unstable psychiatric complaints or other systemic diseases affecting quality of life. 4. Pregnant and lactating women. 5. Self reported immune compromised conditions. 6. Substance abuse and or dependence 7. Taking homeopathic treatment for any chronic diseases within last 6 months.

Design outcomes

Primary

MeasureTime frame
Psoriasis Area Severity index (PASI)Timepoint: Baseline and after 6 months

Secondary

MeasureTime frame
Dermatology Life Quality Index (DLQI)Timepoint: Baseline and after 6 months

Countries

India

Contacts

Public ContactDr Pralay Sharma

Tantiya University, Sri Ganganagar

camdrchakraborty@gmail.com9413377441

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026